Utah Medical Products Inc
Research Utah Medical Products Inc (UTMD) on Bullrun: valuation model: 1.8% overvalued, market cap USD 225.87M, P/E 21.6, dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerUTMD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal1.8% overvalued
- Market capUSD 225.87M
- P/E21.6
- Dividend yield1.7%
- Financial periodQ1 2026
- RevenueUSD 8.72M
- Net incomeUSD 2.60M
- Free cash flowUSD 13.02M
- Gross margin249.3%
Valuation Snapshot
Bullrun's latest valuation model marks Utah Medical Products Inc as 1.8% overvalued; latest market cap is USD 225.87M; P/E is 21.6; dividend yield is 1.7%.
Peer valuation comparison
Latest P/E is 21.61x versus a Healthcare sector median of 24.46x (11.7% below).
Latest dividend yield is 1.7% versus a Healthcare sector median of 2.11% (19.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 38.52M | USD 11.29M | USD 14.32M | 57.1% | 3.48 | USD 85.76M | USD 0 | USD 119.27M |
| FY2024 | USD 40.90M | USD 13.87M | USD 14.60M | 59.0% | 3.96 | USD 82.98M | USD 0 | USD 117.43M |
| FY2023 | USD 50.22M | USD 16.64M | USD 21.64M | 59.8% | 4.57 | USD 92.87M | USD 0 | USD 128.31M |
| FY2022 | USD 52.28M | USD 16.47M | USD 20.34M | 61.6% | 4.52 | USD 75.05M | USD 0 | USD 114.25M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 225.87M | 21.6 | 1.7% | 1.24 |
| 2025 | 2025-12-31 | USD 178.30M | 16.1 | 2.2% | 1.24 |
| 2024 | 2024-12-31 | USD 205.01M | 15.6 | 2.0% | 1.21 |
| 2023 | 2023-12-29 | USD 305.68M | 18.1 | 1.4% | 1.2 |
| 2022 | 2022-12-30 | USD 364.68M | 22.9 | 1.2% | 1.17 |
| 2021 | 2021-12-31 | USD 365.50M | 24.8 | 2.9% | 2.87 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.24 USD, yield 1.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.24 USD |
| FY2024 | 1.21 USD |
| FY2023 | 1.2 USD |
| FY2022 | 1.17 USD |
About Utah Medical Products Inc
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Utah Medical Products Inc overvalued or undervalued?
Bullrun's valuation model currently marks Utah Medical Products Inc as 1.8% overvalued.
What is Utah Medical Products Inc's market cap?
Utah Medical Products Inc's market capitalization is USD 225.87M.
What is Utah Medical Products Inc's P/E ratio?
Utah Medical Products Inc's price-to-earnings (P/E) ratio is 21.6.
Does Utah Medical Products Inc pay a dividend?
Utah Medical Products Inc has a dividend yield of 1.7%.
What does Utah Medical Products Inc do?
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.